论文部分内容阅读
目的探究化疗栓塞术联合射频消融治疗与单纯化疗栓塞术临床疗效比较。方法选取莱州市人民医院收治的48例肝癌患者作为研究对象,按照治疗方法的不同,采取化疗栓塞术联合射频消融治疗手段的设为试验组,单纯采用化疗栓塞术手段的设为对照组,比较两组患者在接受治疗6个月后疗效。结果试验组的最大肿瘤直径和血清甲胎蛋白含量明显低于对照组(P<0.05),且试验组中的整体疗效也优于对照组(P<0.05),两组患者的不良反应发生情况差异无统计学意义(P>0.05)。结论化疗栓塞术联合射频消融治疗在肝癌治疗中的临床疗效优于单纯使用肝动脉化疗栓塞术,值得在临床推广。
Objective To investigate the clinical efficacy of chemoembolization combined with radiofrequency catheter ablation and chemotherapy alone. Methods Forty-eight patients with HCC who were treated in Laizhou People’s Hospital were enrolled in this study. According to the different treatment methods, chemotherapy and embolization combined with radiofrequency catheter ablation were used as the experimental group, and the chemotherapy alone embolization method was used as the control group. Two groups of patients receiving treatment for 6 months after treatment. Results The maximum tumor diameter and the serum level of alpha-fetoprotein in the experimental group were significantly lower than those in the control group (P <0.05), and the overall efficacy in the experimental group was also better than that in the control group (P <0.05). The incidence of adverse reactions The difference was not statistically significant (P> 0.05). Conclusions Chemoembolization combined with radiofrequency ablation is superior to hepatic arterial chemoembolization in the treatment of liver cancer, which is worthy of clinical application.